Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Anacor Pharmaceuticals Inc    

ANACOR PHARMACEUTICALS INC
Mes dernières consult.
Most popular
  Report  
 SummaryNewsCalendarCompanyFinancials 
Company
Anacor Pharmaceuticals, Inc. develops medical solutions.The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform.The company was founded by Lucy Shapiro, Stephen J.... 
More about the company
Latest news on ANACOR PHARMACEUTICALS INC
2016Jazz Pharmaceuticals Agrees to Buy Celator for About $1.5 Billion
DJ
2016Jazz Pharmaceuticals Nears Deal to Buy Celator for About $1.5 Billion
DJ
2016Anacor received rival bid before Pfizer deal - filing
RE
2016Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Ana..
BU
2016Levi & Korsinsky, LLP Announces Investigation Into Whether the Sale of Anacor..
BU
2016ANACOR SHAREHOLDER NOTICE : Faruqi & Faruqi, LLP Announces the Investigation of ..
BU
2016Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Ana..
PR
2016Levi & Korsinsky, LLP Announces Investigation Regarding the Fairness of the S..
BU
2016ANACOR PHARMACEUTICALS SHAREHOLDER A : Former SEC Attorney Willie Briscoe and Po..
BU
2016RYAN & MANISKAS, LLP : Announces Investigation of Anacor Pharmaceuticals, Inc.
PR
More news
Sector news : Biotechnology & Medical Research - NEC
05/25The Heated Quest for Opioid Alternatives -2-
DJ
05/25The Heated Quest for Opioid Alternatives
DJ
05/18GLAXOSMITHKLINE : Regulators flag possible birth defect link to GSK's HIV drug
RE
05/11Trump's Plan to Cut Drug Prices Leaves Industry Relieved
DJ
05/09Drugmaker GSK rings in more change as CFO heads for exit in 2019
RE
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
2017We're Hesitant On AnaptysBio's IPO 
2017MERGERS AND ACQUISITIONS IN 2016 : Pause For Breath In A Shifting Market 
2016New Oral Psoriasis Drug Tops Cellceutix Catalysts 
2016BIOTECH FORUM DAILY DIGEST : A Volatile Few Days, Some Small Caps Blow Up, Spotl.. 
2016Novan's IPO - Buying A Dollar For Twenty Cents 
Income Statement Evolution
Managers
NameTitle
Douglas E. Giordano President, Chief Executive Officer & Director
Graeme Bell Chief Financial Officer & Executive Vice President
Jacob J. Plattner Senior Vice President-Research
Margaret M. Madden Director & Vice President
Bryan Supran Director
Sector and Competitors
1st jan.Capitalization (M$)
ANACOR PHARMACEUTICALS INC0
CELLTRION, INC.--.--%32 036
IQVIA HOLDINGS INC2.66%20 818
LONZA GROUP2.20%20 226
INCYTE CORPORATION-29.61%14 505
NEKTAR THERAPEUTICS33.89%13 705